tobramycin has been researched along with moxifloxacin in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 16 (41.03) | 29.6817 |
2010's | 17 (43.59) | 24.3611 |
2020's | 6 (15.38) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN | 1 |
Alfonso, EC; Karp, CL; Miller, D; Munir, WM; Rosenfeld, SI; Udell, I | 1 |
Jhanji, V; Satpathy, G; Sharma, N; Titiyal, J | 1 |
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT | 1 |
Eisen, L; Kim, J; Rosenberg, J | 1 |
Giannoni, AG; Miller, WL; Perrigin, J | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
Agarwal, T; Chawla, B; Nayak, N; Satpathy, G; Shah, VM; Sharma, N; Tandon, R; Titiyal, JS; Vajpayee, RB | 1 |
Brooks, CW; Demartelaere, SL; Johnson, AJ | 1 |
Alfonso, EC; Almeida, DR; Miller, D | 1 |
Bansal, S; Sachdev, R; Sharma, N; Sinha, R; Titiyal, JS | 1 |
Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Agarwal, P; Bansal, S; Goel, M; Sharma, N; Titiyal, JS; Upadhyaya, AD; Vajpayee, RB | 1 |
Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A | 1 |
Ohashi, Y; Suzuki, T | 1 |
Baviera, J; Beltran, J; Djodeyre, MR; Llovet-Osuna, F; Llovet-Rausell, A; Ortega-Usobiaga, J | 1 |
Fulcher, LC; Johnson, D; Jorgensen, J; Kiel, JW; McElmeel, ML; Montes, JA | 1 |
Gregory, DG | 1 |
Borgman, CJ | 1 |
Atta, S; Bhat, AK; Dhaliwal, D; Durrani, AF; Jhanji, V; Kowalski, RP; Mammen, A | 1 |
Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF | 1 |
Berry, N; Byrne, DP; Fernig, DG; Foulkes, DM; Haneef, AS; Kaye, SB; McLean, K; Rustidge, S; Sloniecka, M; Winstanley, C | 1 |
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
Ding, Y; Jiang, M; Wan, X; Xie, F; Zhang, J | 1 |
3 trial(s) available for tobramycin and moxifloxacin
Article | Year |
---|---|
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome | 2007 |
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome; Visual Acuity; Young Adult | 2010 |
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prevalence; Prospective Studies; Quinolines; Therapeutic Equivalency; Tobramycin; Treatment Outcome; Visual Acuity | 2013 |
36 other study(ies) available for tobramycin and moxifloxacin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2016 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin | 2005 |
Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Ascomycota; Aza Compounds; Cefazolin; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Ophthalmic Solutions; Quinolines; Tobramycin | 2007 |
Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2007 |
Moxifloxacin for bacterial keratitis.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome | 2008 |
A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.
Topics: Adult; Anti-Infective Agents; Antifungal Agents; Aza Compounds; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Quinolines; Tobramycin | 2008 |
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current.
Topics: Aza Compounds; Biofilms; Electricity; Fluoroquinolones; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 2009 |
Spontaneous subconjunctival abscess because of Haemophilus influenzae.
Topics: Abscess; Adult; Anti-Infective Agents; Aza Compounds; Conjunctival Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Moxifloxacin; Quinolines; Tobramycin; Tomography, X-Ray Computed; Vancomycin | 2010 |
Tsukamurella: an emerging opportunistic ocular pathogen.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Conjunctivitis, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Opportunistic Infections; Quinolines; Tobramycin | 2010 |
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amnion; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Aza Compounds; Benzamidines; Carboxymethylcellulose Sodium; Cefazolin; Chlorhexidine; Corneal Ulcer; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pain; Quinolines; Stevens-Johnson Syndrome; Tobramycin; Treatment Outcome; Tropanes; Visual Acuity | 2011 |
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin | 2013 |
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2013 |
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin | 2013 |
Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Incidence; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Moxifloxacin; Myopia; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Tobramycin; Visual Acuity; Young Adult | 2015 |
Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
Topics: Anti-Bacterial Agents; Drug Stability; Drug Storage; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Infertility; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Temperature; Time Factors; Tobramycin; Vancomycin | 2016 |
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity | 2016 |
Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus thuringiensis; Conjunctivitis, Bacterial; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Recurrence; Tobramycin | 2018 |
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Combinations; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vancomycin | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim | 2022 |
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity.
Topics: ADP Ribose Transferases; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Fluoroquinolones; Genotype; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Conjunctival sac flora and drug susceptibility analysis in normal children in East China.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Conjunctiva; Female; Gatifloxacin; Humans; Lacrimal Apparatus; Male; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus; Tobramycin | 2023 |